<HashMap><database>biostudies-literature</database><scores/><additional><omics_type>Unknown</omics_type><volume>29(5)</volume><submitter>Bauder C</submitter><pubmed_abstract>A convenient protocol for the synthesis of 25,26,27-tribenzoyl-28-[((&lt;i>S&lt;/i>)-1-diphenylphos- phanyl-propan-2-yl)oxy]-calix[4]arene via stereospecific methylation on Evans' oxazolidinone moiety was reported. According to the &lt;sup>13&lt;/sup>C NMR analysis of this phosphine, the calix[4]arene skeleton adopted a 1,3-alternate conformation. The latter conformation of the macrocycle and the (&lt;i>S&lt;/i>)-chirality of the carbon atom bearing the methyl substituent were confirmed by a single-crystal X-ray diffraction study. After coordination of the phosphinated ligand to the dimeric [RuCl&lt;sub>2&lt;/sub>(&lt;i>p&lt;/i>-cymene)]&lt;sub>2&lt;/sub> organometallic precursor, the resulting arene-ruthenium complex was tested in the asymmetric reduction of acetophenone and alcohol was obtained with modest enantiomeric excess.</pubmed_abstract><journal>Molecules (Basel, Switzerland)</journal><pagination>1156</pagination><full_dataset_link>https://www.ebi.ac.uk/biostudies/studies/S-EPMC10934826</full_dataset_link><repository>biostudies-literature</repository><pubmed_title>Optically Pure Calixarenyl Phosphine via Stereospecific Alkylation on Evans' Oxazolidinone Moiety.</pubmed_title><pmcid>PMC10934826</pmcid><pubmed_authors>Semeril D</pubmed_authors><pubmed_authors>Bauder C</pubmed_authors></additional><is_claimable>false</is_claimable><name>Optically Pure Calixarenyl Phosphine via Stereospecific Alkylation on Evans' Oxazolidinone Moiety.</name><description>A convenient protocol for the synthesis of 25,26,27-tribenzoyl-28-[((&lt;i>S&lt;/i>)-1-diphenylphos- phanyl-propan-2-yl)oxy]-calix[4]arene via stereospecific methylation on Evans' oxazolidinone moiety was reported. According to the &lt;sup>13&lt;/sup>C NMR analysis of this phosphine, the calix[4]arene skeleton adopted a 1,3-alternate conformation. The latter conformation of the macrocycle and the (&lt;i>S&lt;/i>)-chirality of the carbon atom bearing the methyl substituent were confirmed by a single-crystal X-ray diffraction study. After coordination of the phosphinated ligand to the dimeric [RuCl&lt;sub>2&lt;/sub>(&lt;i>p&lt;/i>-cymene)]&lt;sub>2&lt;/sub> organometallic precursor, the resulting arene-ruthenium complex was tested in the asymmetric reduction of acetophenone and alcohol was obtained with modest enantiomeric excess.</description><dates><release>2024-01-01T00:00:00Z</release><publication>2024 Mar</publication><modification>2026-06-26T03:26:01.193Z</modification><creation>2025-04-06T14:32:56.244Z</creation></dates><accession>S-EPMC10934826</accession><cross_references><pubmed>38474667</pubmed><doi>10.3390/molecules29051156</doi></cross_references></HashMap>